Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT01286818
Status:
COMPLETED
Last Update Posted:
2014-10-06
First Post:
2011-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-25
First Submit QC Date:
None
Study First Post Date:
2011-01-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-16
Results First Submit QC Date:
None
Results First Post Date:
2014-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-03
Last Update Post Date:
2014-10-06
Last Update Post Date Type:
ESTIMATED